Lam Research (LRCX) Cash & Equivalents (2009 - 2026)

Lam Research's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $4.8 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 12.84% year-over-year to $4.8 billion; the TTM figure through Mar 2026 stood at $4.8 billion (down 12.84% YoY), while the FY2025 annual figure was $6.4 billion, up 9.28% from the prior year.
• Cash & Equivalents was $4.8 billion for Q1 2026 at Lam Research, down from $6.2 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $6.7 billion in Q3 2025 to a low of $3.5 billion in Q2 2022.
• Historically, Cash & Equivalents has averaged $5.3 billion across 5 years, with a median of $5.5 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents fell 20.29% in 2022, then soared 51.53% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $4.5 billion in 2022, then gained by 25.39% to $5.6 billion in 2023, then climbed by 0.75% to $5.7 billion in 2024, then gained by 9.09% to $6.2 billion in 2025, then declined by 23.13% to $4.8 billion in 2026.
• The last three Cash & Equivalents figures came in at $4.8 billion (Q1 2026), $6.2 billion (Q4 2025), and $6.7 billion (Q3 2025), per Business Quant data.